Table 1

Demographic and clinical data on patients at baseline

Etidronate/placebo (n=24) Etidronate/NaF (n=23)
Age (y)60 (17)56 (17)
Men95
Women1518
Premenopausal53
Postmenopausal1015
Height (cm)168 (8)165 (10)
Weight (kg)71 (12)66 (11)
RA1211
SLE64
Other
 Connective tissue disorder44
 COPD12
 Transplantation10
Disease duration (y)9 (9)10 (10)
Corticosteroids, cumulative (g)10.7 (5.9)14.6 (14.9)
Corticosteroids, baseline (mg/day)16.9 (19.8)10.6 (4.2)
BMD, lumbar spine (g/cm2)0.944 (0.167)0.804 (0.142)**
BMD, hips (g/cm2)0.679 (0.194)0.6 (0.112)
  • No significant differences between groups, except for BMD of lumbar spine at baseline (** p < 0.01). Data shown as mean (SD).